Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

Background: Severe coronavirus disease 2019 (COVID-19) is the result of a hyper-inflammatory reaction to the severe acute respiratory syndrome coronavirus 2. The biomarkers of inflammation have been used to risk-stratify patients with COVID-19. Osteopontin (OPN) is an integrin-binding glyco-phosphop...

Full description

Bibliographic Details
Main Authors: Salim S. Hayek, Christoph Roderburg, Pennelope Blakely, Christopher Launius, Jesper Eugen-Olsen, Frank Tacke, Sofia Ktena, Verena Keitel, Mark Luedde, Evangelos J. Giamarellos-Bourboulis, Tom Luedde, Sven H. Loosen
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
OPN
CRP
PCT
Online Access:https://www.mdpi.com/2077-0383/10/17/3907
id doaj-8bf32e81aa3240b19fcb869cc7eb8c56
record_format Article
spelling doaj-8bf32e81aa3240b19fcb869cc7eb8c562021-09-09T13:49:41ZengMDPI AGJournal of Clinical Medicine2077-03832021-08-01103907390710.3390/jcm10173907Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19Salim S. Hayek0Christoph Roderburg1Pennelope Blakely2Christopher Launius3Jesper Eugen-Olsen4Frank Tacke5Sofia Ktena6Verena Keitel7Mark Luedde8Evangelos J. Giamarellos-Bourboulis9Tom Luedde10Sven H. Loosen11Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAClinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, GermanyDivision of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADivision of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADepartment of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, 2650 Hvidovre, DenmarkDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medial School, 12462 Athens, GreeceClinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, GermanyKGP Bremerhaven, Postbrookstraße 103, 27574 Bremerhaven, Germany4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medial School, 12462 Athens, GreeceClinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, GermanyClinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, GermanyBackground: Severe coronavirus disease 2019 (COVID-19) is the result of a hyper-inflammatory reaction to the severe acute respiratory syndrome coronavirus 2. The biomarkers of inflammation have been used to risk-stratify patients with COVID-19. Osteopontin (OPN) is an integrin-binding glyco-phosphoprotein involved in the modulation of leukocyte activation; its levels are associated with worse outcomes in patients with sepsis. Whether OPN levels predict outcomes in COVID-19 is unknown. Methods: We measured OPN levels in serum of 341 hospitalized COVID-19 patients collected within 48 h from admission. We characterized the determinants of OPN levels and examined their association with in-hospital outcomes; notably death, need for mechanical ventilation, and need for renal replacement therapy (RRT) and as a composite outcome. The risk discrimination ability of OPN was compared with other inflammatory biomarkers. Results: Patients with COVID-19 (mean age 60, 61.9% male, 27.0% blacks) had significantly higher levels of serum OPN compared to healthy volunteers (96.63 vs. 16.56 ng/mL, <i>p</i> < 0.001). Overall, 104 patients required mechanical ventilation, 35 needed dialysis, and 53 died during their hospitalization. In multivariable analyses, OPN levels ≥140.66 ng/mL (third tertile) were associated with a 3.5 × (95%CI 1.44–8.27) increase in the odds of death, and 4.9 × (95%CI 2.48–9.80) increase in the odds of requiring mechanical ventilation. There was no association between OPN and need for RRT. Finally, OPN levels in the upper tertile turned out as an independent prognostic factor of event-free survival with respect to the composite endpoint. Conclusion: Higher OPN levels are associated with increased odds of death and mechanical ventilation in patients with COVID-19, however, their utility in triage is questionable.https://www.mdpi.com/2077-0383/10/17/3907OPNCRPprocalcitoninPCTcoronavirus disease 2019SARS-CoV-2
collection DOAJ
language English
format Article
sources DOAJ
author Salim S. Hayek
Christoph Roderburg
Pennelope Blakely
Christopher Launius
Jesper Eugen-Olsen
Frank Tacke
Sofia Ktena
Verena Keitel
Mark Luedde
Evangelos J. Giamarellos-Bourboulis
Tom Luedde
Sven H. Loosen
spellingShingle Salim S. Hayek
Christoph Roderburg
Pennelope Blakely
Christopher Launius
Jesper Eugen-Olsen
Frank Tacke
Sofia Ktena
Verena Keitel
Mark Luedde
Evangelos J. Giamarellos-Bourboulis
Tom Luedde
Sven H. Loosen
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
Journal of Clinical Medicine
OPN
CRP
procalcitonin
PCT
coronavirus disease 2019
SARS-CoV-2
author_facet Salim S. Hayek
Christoph Roderburg
Pennelope Blakely
Christopher Launius
Jesper Eugen-Olsen
Frank Tacke
Sofia Ktena
Verena Keitel
Mark Luedde
Evangelos J. Giamarellos-Bourboulis
Tom Luedde
Sven H. Loosen
author_sort Salim S. Hayek
title Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
title_short Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
title_full Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
title_fullStr Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
title_full_unstemmed Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
title_sort circulating osteopontin levels and outcomes in patients hospitalized for covid-19
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-08-01
description Background: Severe coronavirus disease 2019 (COVID-19) is the result of a hyper-inflammatory reaction to the severe acute respiratory syndrome coronavirus 2. The biomarkers of inflammation have been used to risk-stratify patients with COVID-19. Osteopontin (OPN) is an integrin-binding glyco-phosphoprotein involved in the modulation of leukocyte activation; its levels are associated with worse outcomes in patients with sepsis. Whether OPN levels predict outcomes in COVID-19 is unknown. Methods: We measured OPN levels in serum of 341 hospitalized COVID-19 patients collected within 48 h from admission. We characterized the determinants of OPN levels and examined their association with in-hospital outcomes; notably death, need for mechanical ventilation, and need for renal replacement therapy (RRT) and as a composite outcome. The risk discrimination ability of OPN was compared with other inflammatory biomarkers. Results: Patients with COVID-19 (mean age 60, 61.9% male, 27.0% blacks) had significantly higher levels of serum OPN compared to healthy volunteers (96.63 vs. 16.56 ng/mL, <i>p</i> < 0.001). Overall, 104 patients required mechanical ventilation, 35 needed dialysis, and 53 died during their hospitalization. In multivariable analyses, OPN levels ≥140.66 ng/mL (third tertile) were associated with a 3.5 × (95%CI 1.44–8.27) increase in the odds of death, and 4.9 × (95%CI 2.48–9.80) increase in the odds of requiring mechanical ventilation. There was no association between OPN and need for RRT. Finally, OPN levels in the upper tertile turned out as an independent prognostic factor of event-free survival with respect to the composite endpoint. Conclusion: Higher OPN levels are associated with increased odds of death and mechanical ventilation in patients with COVID-19, however, their utility in triage is questionable.
topic OPN
CRP
procalcitonin
PCT
coronavirus disease 2019
SARS-CoV-2
url https://www.mdpi.com/2077-0383/10/17/3907
work_keys_str_mv AT salimshayek circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT christophroderburg circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT pennelopeblakely circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT christopherlaunius circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT jespereugenolsen circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT franktacke circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT sofiaktena circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT verenakeitel circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT markluedde circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT evangelosjgiamarellosbourboulis circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT tomluedde circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
AT svenhloosen circulatingosteopontinlevelsandoutcomesinpatientshospitalizedforcovid19
_version_ 1717759953055252480